donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > 00399 INNOVATIVE PHAR > Company Executives
00399 INNOVATIVE PHAR
0.1850.0000.00%
NamePositionSalaryService DateEducationAgeGenderUpdated
高源兴Executive director,Authorized representative1.36M01/04/2016--67male08/05/2022
唐榕Executive director548.00K09/26/2014Bachelor55male08/05/2022
蒋年Non-Executive Director,Remuneration committee member,Chairman,Chairman of the nomination committee60.00K12/21/2010Bachelor68female08/05/2022
肖焱Non-Executive Director60.00K05/22/2012Bachelor43female08/05/2022
邬燕敏Non-Executive Director60.00K06/08/2011Bachelor45female08/05/2022
陈伟君Independent non-executive director,Chairman of the audit committee80.00K11/06/2009--65female08/05/2022
王荣樑Chairman of the remuneration committee,Nominating committee member,Independent non-executive director,Member of the audit committee60.00K06/08/2011Bachelor72male08/05/2022
陈金中Nominating committee member,Remuneration committee member,Member of the audit committee,Independent non-executive director55.00K02/01/2021Doctor57male08/05/2022
潘汉彦Joint Chief Financial Officer,Company secretary,Authorized representative--05/14/2013--56male08/05/2022
毛裕民Chief scientific adviser,Honorary chairman--09/01/2010Doctor70male08/05/2022
洪诚Legal representative--08/10/2004--67male08/05/2022
Company Overview More
Pilot Pharmaceutical and Biotechnology Co., Ltd. is a Hong Kong investment holding company mainly engaged in pharmaceutical and biotechnology business. The company operates through five major divisions. The genetic testing Services Division provides genetic testing services in China and Hong Kong. Bio-industry products division distributes bio-industry products in China. Beauty equipment and products Trading Division is engaged in the trade of beauty equipment and products in Hong Kong, China. The securities investment division engages in securities investment in Hong Kong, China and outside Hong Kong, China. The R & D division is engaged in the R & D and commercialization of oral insulin products.
CEO: Nian Jiang
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...